Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05562258 · ClinicalTrials.gov registry record · NA

Development and Testing of a Peer-Coaching Model for the Treatment of Eating Disorders

A NA study of Eating Disorder, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT05562258: Recruiting NA study of Eating Disorder, sponsored by Icahn School of Medicine at Mount Sinai.

NCT05562258 is a NA study of Eating Disorder that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 70 participants, below the 112-participant average among 9 other Eating Disorder trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05562258, a NA study of Eating Disorder, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

This project includes developing and testing a coaching approach during the treatment of eating disorders. It is expected that with the addition of support outside of regular treatment, caregivers will experience improvements in emotional taxation and patients will strengthen skills necessary for recovery. Twelve weeks of coaching will be incorporated into standard treatment. Randomization will occur placing participants into (1) parent coaching + patient educational materials or (2) parent educational materials + patient coaching.

Primary Outcome

Changes in patient self-efficacy will be measured using the EDRSQ, which is a 23-item instrument that assesses self-efficacy with eating disorder behaviors and attitudes. Total scores range from 1-5 with higher scores indicating greater self-efficacy. Changes in self-efficacy will be calculated using the baseline and 12-week scores from the EDRSQ.

Conditions Studied

Interventions

  • BEHAVIORAL Parent Coaching and Patient Education
  • BEHAVIORAL Parent Education and Patient Coaching

Study Locations (1)

New York

  • Department of Psychiatry, Eating and Weight Disorders Program - New York

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2023-05-01
Est. Completion 2026-10
Phase NA

What NCT05562258 shows while recruiting

NCT05562258 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 112-participant average among 9 other Eating Disorder trials with a reported enrollment target (37% lower).

The record links to 1 condition, with Eating Disorder appearing as the primary indexed condition, and to 2 interventions - of which Parent Coaching and Patient Education is the first listed.

NCT05562258 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05562258 about?

NCT05562258 is a clinical study titled "Development and Testing of a Peer-Coaching Model for the Treatment of Eating Disorders". This project includes developing and testing a coaching approach during the treatment of eating disorders. It is expected that with the addition of support outside of regular treatment, caregivers will experience improvements in emotional taxation and patients will strengthen skills necessary for re...

What is the current status of trial NCT05562258?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2023-05-01. Estimated completion is 2026-10.

What conditions does trial NCT05562258 study?

This clinical trial studies the following conditions: Eating Disorder.

What interventions are being tested in trial NCT05562258?

The interventions under investigation include: Parent Coaching and Patient Education (BEHAVIORAL), Parent Education and Patient Coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT05562258?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05562258 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Eating Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05562258's enrollment target sits among peer trials

70 6th of 9 higher than 4 of 9 other Eating Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Eating Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05562258, the US trial registry maintained by the National Library of Medicine. NCT05562258 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.